The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study

Menzies, 2017, Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab, Ann Oncol, 28, 368, 10.1093/annonc/mdw443 Toi, 2019, Profiling preexisting antibodies in patients treated with anti–PD-1 therapy for advanced non–small cell lung cancer, JAMA Oncol, 5, 376, 10.1001/jamaoncol.2018.5860 Kimbara, 2018, Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab, Cancer Sci, 109, 3583, 10.1111/cas.13800 Matsuura, 2018, Fulminant onset of insulin-dependent diabetes with positive anti-GAD antibody titers during treatment with nivolumab in a patient with NSCLC, Cancer Immunol Immunother, 67, 1417, 10.1007/s00262-018-2203-3 Nishioka, 2005, Detection of various platelet-associated immunoglobulins by flow cytometry in idiopathic thrombocytopenic purpura, Cytometry B Clin Cytom, 68, 37, 10.1002/cyto.b.20067 Murai, 2011, Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey, J Neurol Sci, 305, 97, 10.1016/j.jns.2011.03.004 Segni, 2014, High prevalence of antinuclear antibodies in children with thyroid autoimmunity, J Immunol Res, 2014, 150239 Kiyohara, 2018, Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: an interim analysis of a postmarketing surveillance, J Dermatol, 45, 408, 10.1111/1346-8138.14227 Orlov, 2015, Induction of painless thyroiditis in patients receiving programmed death 1 receptor immunotherapy for metastatic malignancies, J Clin Endocrinol Metab, 100, 1738, 10.1210/jc.2014-4560 Kobayashi, 2018, Patients with antithyroid antibodies are prone to develop destructive thyroiditis by nivolumab: a prospective study, J Endocr Soc, 2, 241, 10.1210/js.2017-00432 Iwaoka, 2003, A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies, Endocr J, 50, 225, 10.1507/endocrj.50.225 Kahara, 2003, Fulminating onset type 1 diabetes with positivity for anti-GAD antibody and elevated pancreatic exocrine enzyme concentrations, Inter Med, 42, 517, 10.2169/internalmedicine.42.517 Makino, 2009, A case of abrupt onset autoimmune type 1 diabetes mimicking fulminant type 1 diabetes, Endocr J, 56, 1113, 10.1507/endocrj.K09E-074 Cheema, 2018, Autoimmune diabetes associated with pembrolizumab: a review of published case reports, World J Oncol, 9, 1, 10.14740/wjon1085w Ansari, 2003, The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice, J Exp Med, 198, 63, 10.1084/jem.20022125 Hayashi, 2008, Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period, Mod Rheumatol, 18, 153, 10.3109/s10165-008-0028-1 Morimoto, 2020, Impact of preexisting antinuclear antibodies on combined immunotherapy and chemotherapy in advanced non-small cell lung cancer patients, Med Oncol, 37, 1, 10.1007/s12032-020-01440-3